Pharmacovigilance & Safety Services: Safeguarding Patient Outcomes in Drug Development
Product Introduction
In the high-stakes arena of pharmaceutical advancement, pharmacovigilance (PV) and safety monitoring are essential for identifying, assessing, and mitigating risks associated with therapeutic products. As vital pillars of our CRO (Contract Research Organization) offerings, our Pharmacovigilance & Safety services provide comprehensive oversight from clinical trials to post-marketing surveillance, ensuring regulatory compliance and patient protection. Drawing on global standards like ICH E2, GVP (Good Pharmacovigilance Practices), FDA MedWatch, and NMPA requirements, we empower biopharma sponsors to navigate safety challenges with confidence, turning potential risks into actionable insights for safer therapies.
Key Advantages & Features
Our PV services go beyond compliance—they proactively enhance product safety profiles and accelerate market access. With a 24/7 global operations center and expertise in over 50 therapeutic areas, we handle complex safety signals for small molecules, biologics, and medical devices alike.
|
Advantage/Feature |
Description |
|
Global Expertise Network |
Dedicated team of PV specialists, physicians, and epidemiologists with 20+ years of experience, managing 200+ active programs annually with 100% on-time reporting. |
|
Cutting-Edge Technology Suite |
AI-enabled signal detection, Argus/ARISg databases, and automated ICSR workflows reduce processing time by 50% while upholding ALCOA+ principles. |
|
Cost-Effective Scalability |
Tailored solutions for startups to multinationals, saving up to 30% through predictive analytics and outsourced models. |
|
Proven Risk Management |
Integrated safety governance with mock inspections and CAPA frameworks, resulting in zero regulatory observations in recent EMA audits. |
|
24/7 Global Surveillance |
Multi-language ICSR intake from diverse sources, including social media, with rapid triage for expedited reporting. |
|
Lifecycle Integration |
Seamless linkage to clinical data management for DSURs and RMPs, supporting adaptive strategies in oncology and rare diseases. |
Product Types
We deliver a modular, end-to-end PV ecosystem designed for seamless integration into your clinical or commercial pipeline:
Case Processing & Intake
Global ICSR management with eVAERS/eMDR integrations for rapid triage.
Signal Detection & Risk Management
AI disproportionality analysis and RMP development with REMS/ PASS design.
Regulatory Reporting & Submissions
Automated PSURs/PBRERs and E2B(R3) filings for FDA/EMA/NMPA.
Safety Training & Governance
Customized GVP programs and audit readiness assessments.
Post-Marketing & Lifecycle Support
Literature screening, patient registries, and RWE generation.
Oncology-Specific PV Modules
Tailored signal monitoring for immuno-oncology with enhanced causality assessments.
Product Applications
Our services apply across therapeutic areas and lifecycle stages, fortifying safety in complex environments:
Clinical Trials: DSUR generation and interim safety reviews for Phase I-III oncology or gene therapy studies.
Post-Marketing Surveillance: Ongoing ICSR processing for biologics, monitoring real-world AEs in chronic therapies like diabetes.
Rare Diseases & Advanced Therapies: RMPs for orphan drugs, with cohort studies to assess long-term risks.
Global Regulatory Filings: Expedited submissions for breakthrough therapies, bridging NMPA/EMA/FDA requirements.
Biologics & Vaccines: Signal detection in mRNA platforms, ensuring benefit-risk balance during pandemics.
Crisis Response: Ad-hoc support for recalls or hypersensitivity events, minimizing trial disruptions.